Design of a group-randomized Streptococcus pneumoniae vaccine trial

Controlled Clinical Trials

Volumn 22, Issue 4, 2001, Pages 438-452

  Moulton, Lawrence H ^a   O'Brien, Katherine L ^a,c   Kohberger, Robert ^b   Chang, Ih ^b   Reid, Raymond ^a   Weatherholtz, Robert ^a   Hackell, Jill G ^b   Siber, George R ^b   Santosham, Mathuram ^a,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b PFIZER INC   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Group randomized trial; Streptococcus pneumoniae; Vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; METHODOLOGY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; POPULATION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ARIZONA; CHILD, PRESCHOOL; CLINICAL TRIALS, PHASE III; HUMANS; IMMUNOTHERAPY, ACTIVE; INDIANS, NORTH AMERICAN; INFANT; MODELS, STATISTICAL; NEW MEXICO; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PROBABILITY; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLE SIZE; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; UTAH;

EID: 0034886473     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(01)00132-5     Document Type: Article

References (28)

1. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance
2. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later
3. The epidemiology of pneumococcal infection in children in the developing world
4. Bacterial etiology of serious infections in young infants in developing countries: Results of a multicenter study
5. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries
6. New vaccine development: Establishing priorities, Volume II
7. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
8. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community
9. Invasive pneumococcal disease in an Alaska Native population, 1980 through 1986
10. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population
11. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990: Ethnic differences and opportunities for prevention
12. Active laboratory based surveillance for invasive Streptococcus pneumoniae (pneumococcus) among Navajo people in the American Southwest, 1989-1996
13. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
14. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases
15. Reemergence of invasive haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska
16. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: High efficacy and lack of herd immunity
17. Estimation of the indirect effect of Hib conjugate vaccine in an American Indian population
18. Direct and indirect effects in vaccine efficacy and effectiveness
19. Study designs for evaluating different efficacy and effectiveness aspects of vaccines
20. Herd immunity: History, theory, practice
21. A review of the design of vaccine efficacy trials and a proposal for the design of the VA Cooperative Study of Active Immunotherapy of HIV Infection
22. Immunoblot detection of multiple serotypes of Streptococcus pneumoniae (Pnc) in nassopharyngeal (NP) specimens using monoclonal antibodies (MAb)
23. Some further notes on the use of matrices in population mathematics
24. Community Intervention Trial for Smoking Cessation (COMMIT): Summary of design and intervention
25. Preparation for a pneumococcal vaccine trial in The Gambia: Individual or community randomisation?
26. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda